NDC 0641-6135-01 - Prochlorperazine Edisylate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-6135
- Requested NDC
- 0641-6135-01
- Package NDCs from labels
- 0641-6135-01, 0641-6135-25
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Effective date
- 2025-01-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Prochlorperazine Edisylate Injection, USP | Hikma Pharmaceuticals USA Inc. | 2025-01-29 | HUMAN PRESCRIPTION DRUG LABEL |
| PROCHLORPERAZINE EDISYLATE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-30 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0641-6135-01 | Prochlorperazine Edisylate | 2 mL in 1 VIAL | INJECTION | 2 | 7 | |
| 0641-6135-25 | Prochlorperazine Edisylate | 25 in 1 CARTON | INJECTION | 25 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-6135-01 | ML - Milliliter | 0641-6135 | c57f245a-6b8b-4af3-8c94-37178969094f | 1 | 2016-11-08 |
| 0641-6135-25 | ML - Milliliter | 0641-6135 | 64870d1d-901a-4468-98a4-a95dc6523b8e | 1 | 2016-11-08 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| PROCHLORPERAZINE EDISYLATE | ACTIVE INGREDIENT | PG20W5VQZS | PROCHLORPERAZINE EDISYLATE INJECTION [WEST-WARD PHARMACEUTICALS CORP.] | 2 | |
| PROCHLORPERAZINE | ACTIVE MOIETY | YHP6YLT61T | PROCHLORPERAZINE EDISYLATE INJECTION [WEST-WARD PHARMACEUTICALS CORP.] | 2 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | PROCHLORPERAZINE EDISYLATE INJECTION [WEST-WARD PHARMACEUTICALS CORP.] | 2 | |
| SACCHARIN SODIUM | INACTIVE INGREDIENT | SB8ZUX40TY | PROCHLORPERAZINE EDISYLATE INJECTION [WEST-WARD PHARMACEUTICALS CORP.] | 2 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | PROCHLORPERAZINE EDISYLATE INJECTION [WEST-WARD PHARMACEUTICALS CORP.] | 2 | |
| SODIUM TARTRATE DIHYDRATE | INACTIVE INGREDIENT | DIA7C37AOW | PROCHLORPERAZINE EDISYLATE INJECTION [WEST-WARD PHARMACEUTICALS CORP.] | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | PROCHLORPERAZINE EDISYLATE INJECTION [WEST-WARD PHARMACEUTICALS CORP.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| InterSol | PLATELET ADDITIVE 3 | Fenwal, Inc. | e4f06c0b-7cb1-49c9-97a4-2cfc21298495 | 2021-11-16 | Warnings, Adverse reactions | 593YOG76RN |
| Solucion InterSol | SOLUCION ADITIVA PARA PLAQUETAS 3 | Fenwal, Inc. | d5eaf5f4-67d3-4475-af9a-f5b0f882f5d1 | 2021-10-04 | Warnings, Adverse reactions | 593YOG76RN |
| Sterile Water | STERILE WATER | B. Braun Medical Inc. | d99f9133-e4d0-4dee-b611-dbc3f918b547 | 2021-08-09 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | B. Braun Medical Inc. | 8924e52e-8622-4ed6-a061-1908183e0a18 | 2021-08-06 | Warnings, Adverse reactions | 059QF0KO0R |
| Sodium Phosphates | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | Fresenius Kabi USA, LLC | e6169d3b-39d2-47f9-8d5b-b53ec069a722 | 2021-07-23 | Warnings, Adverse reactions | 593YOG76RN |
| Eyewash | EYEWASH | Global Equipment Company | c4f78121-4668-2e0c-e053-2995a90ab6c6 | 2021-06-17 | Warnings | 059QF0KO0R |
| PROCHLORPERAZINE EDISYLATE | PROCHLORPERAZINE EDISYLATE | Baxter Healthcare Corporation | 11cb37c7-01b4-4223-b2ea-a3695639b80b | 2021-04-26 | Boxed warning, Warnings, Adverse reactions | 2102949 PG20W5VQZS |
| Sterile Water | WATER | Asclemed USA, Inc. | 45c38269-883c-4198-a9d5-03810a4420ec | 2021-01-14 | Warnings, Adverse reactions | 059QF0KO0R |
| InterSol | PLATELET ADDITIVE 3 | Fenwal, Inc. | a00c4a93-cde2-4753-81f7-0d6fee9fb690 | 2020-10-20 | Warnings, Adverse reactions | 593YOG76RN |
| Bach Original Flower Remedies | WATER | Nelson Bach USA Limited | 09c76050-42c5-4403-865c-a1f6f668d9c0 | 2020-06-15 | Warnings | 059QF0KO0R |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | ee831456-5962-4d5e-ad0c-69ab85860453 | 2020-06-03 | 593YOG76RN | |
| Sterile Water | WATER | Baxter Healthcare Company | 8bcf5572-49e1-4302-9522-56f57904cb4a | 2019-12-29 | Warnings, Adverse reactions | 059QF0KO0R |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | e41adb4e-06fb-4141-ba55-50b043f3c9da | 2019-11-19 | 593YOG76RN | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 14445dfd-6041-40cd-a043-3f4da6bcb9c1 | 2019-11-18 | 593YOG76RN | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 2557199a-5f60-49d8-b093-1e0700211243 | 2019-11-18 | 593YOG76RN | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 794f724c-87f0-49c1-9b26-c9e491978313 | 2019-11-18 | 593YOG76RN | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 5c7d3287-883a-459b-9214-074a583c8a59 | 2019-11-18 | 593YOG76RN | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 448a1dc5-7a98-4b2f-82af-4b92de05cfc3 | 2019-11-18 | 593YOG76RN | |
| Dynamic Eyewash with Eyecup | WATER | Dynamic Safety International | 7d3af0f4-0e1f-9ea5-e053-2991aa0af7a2 | 2018-12-17 | Warnings | 059QF0KO0R |
| Bio Rock Water | ROCK WATER | BioActive Nutritional, Inc. | 178bd16d-0d4f-49d8-866b-8ab3a3c6889d | 2018-07-30 | Warnings | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.